Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The diagnostic thresholds reflected those considered effective for CSG (<30%) or safe for administration of 8-aminoquinolines (>70% or >80%, depending on authoritative recommendations) [25,26]”
In the citing paper
“This is consistent with several studies in SE Asia of the FST and G6PD RDTs, demonstrating their high sensitivities in malaria patients [28] and healthy individuals with enzyme activities < 30% activity [18,29] with a spectrum of mostly WHO class II G6PD variants.”
From Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria (2021) · cites this paper as [29]
In the citing paper
“Other studies have reported the mis-diagnosis of G6PD heterozygous females by the FST and G6PD RDTs with declining test sensitivities, as low as ~70%, with G6PD activities between 30—< 60% in G6PDd heterozygous females [18, 28,29,30] and in an in vitro system of G6PD enzyme inhibition of red blood cells [20].”
From Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria (2021) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evidence and Implications of Mortality Associated with Acute Plasmodium vivax Malaria
Baird, J. K. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00074-12 · Cited by 398
Self-citation
Research works printed but not linked: 35
- MD Cappellini, 2008, Glucose-6-phosphate dehydrogenase deficiency, Lancet, 371, 64, 10.1016/S0140-6736(08)60073-2 · DOI · Paper page
- I Youngster, 2010, Medications and glucose-6-phosphate dehydrogenase deficiency: and evidence-based review, Drug Saf, 33, 713, 10.2165/11536520-000000000-00000 · DOI · Paper page
- RE Howes, 2013, G6PD deficiency: global distribution, genetic variants and primaquine therapy, Adv Parasitol, 81, 133, 10.1016/B978-0-12-407826-0.00004-7 · DOI · Paper page
- JK Baird, 2004, Primaquine therapy for malaria, Clin Infect Dis, 37, 1659, 10.1086/379714 · DOI
- AS Alving, 1956, Enzymatic deficiency in primaquine-sensitive erythrocytes, Science, 124, 484, 10.1126/science.124.3220.484-a · DOI · Paper page
- R Dern, 1954, The hemolytic effect of primaquine. II. The natural course of hemolytic anemia and mechanism of its self-limited character, J Lab Clin Med, 44, 171
- AS Alving, 1960, Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Plasmodium vivax by intermittent regimens of drug administration, Bull WHO, 22, 621
- I Pannacciulli, 1965, The course of experimentally induced hemolytic anemia in a primaquine-sensitive Caucasian: a case study, Blood, 25, 92, 10.1182/blood.V25.1.92.92 · DOI · Paper page
- JN George, 1967, Primaquine sensitivity in Caucasians: hemolytic reactions induced by primaquine in G6PD deficient subjects, J Lab Clin Med, 70, 80
- A Bonsignore, 1964, Relationship between age and enzymatic activities in human erythrocytes from normal and fava bean-sensitive subject, J Clin Invest, 43, 834, 10.1172/JCI104969 · doi:10.1172/jci104969
- S Piomelli, 1968, In vivo liability of glucose-6-phosphate dehydrogenase in GdA- and GdMediterranean deficiency, J Clin Invest, 47, 940, 10.1172/JCI105786 · DOI · Paper page
- E Salvidio, 1967, Nature of hemolytic crises and the fate of G6PD deficient, drug-damaged erythrocytes in Sardinians, New Engl J Med, 276, 1339, 10.1056/NEJM196706152762402 · doi:10.1056/nejm196706152762402
- I Ebisawa, 1972, Malaria in Laos. Primaquine sensitivity of the Laotians and Japanese, Jpn J Exp Med, 42, 415
- SA Chopra, 1968, Hemolytic crisis in a Zanzibari Arab girl with G6PD deficiency and sickle cell trait, East Afr Med J, 45, 726
- M Ziai, 1967, Malaria prophylaxis and treatment in G6PD deficiency: an observation on the toxicity of chloroquine and primaquine, Clin Pediatr, 6, 242, 10.1177/000992286700600416 · doi:10.1177/000992286700600416
- KP Abeyarantne, 1968, Sensitivity to primaquine in Ceylonese children due to deficiency of erythrocytic glucose-6-phosphate dehydrogenase deficiency, Ceylon Med J, 13, 134
- MV Lacerda, 2012, Postmortem characterization of patients with a clinical diagnosis of Plasmodium vivax: to what extent does this parasite kill?, Clin Infect Dis, 55, e67, 10.1093/cid/cis615 · DOI · Paper page
- DF Clyde, 1981, Clinical problems associated with the use of primaquine as a tissue schizontocidal and gametocytocidal drug, Bull WHO, 59, 391
- RE Howes, 2012, G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical-based map, PLoS Med, 9, e1001339, 10.1371/journal.pmed.1001339 · DOI · Paper page
- NM Anstey, 2012, Plasmodium vivax: clinical spectrum, risk factors and pathogenesis, Adv Parasitol, 80, 151, 10.1016/B978-0-12-397900-1.00003-7 · DOI · Paper page
- C Naing, 2014, Is Plasmodium vivax a severe malaria?: a systematic review and meta-analysis, PLoS Negl Trop Dis, 8, e3071, 10.1371/journal.pntd.0003071 · DOI · Paper page
- E Beutler, 1966, A series of new screening procedures for pyruvate kinase deficiency, glucose-6-phosphate dehydrogenase deficiency, and glutathione reductase deficiency, Blood, 28, 553, 10.1182/blood.V28.4.553.553 · DOI
- GJ Domingo, 2013, G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests, Malaria J, 12, 391, 10.1186/1475-2875-12-391 · DOI · Paper page
- L von Seidlein, 2013, Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report, Malaria J, 12, 112, 10.1186/1475-2875-12-112 · DOI · Paper page
- AW Satyagraha, 2015, G6PD deficiency at Sumba in eastern Indonesia is prevalent, diverse and severe: implications for primaquine therapy against relapsing vivax malaria, PLOS Negl Trop Dis, 9, e0003602, 10.1371/journal.pntd.0003602 · DOI · Paper page
- JK Baird, 2015, Non-inferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells, Transl Res, 165, 677, 10.1016/j.trsl.2014.09.009 · DOI · Paper page
- MA Saunders, 2002, Nucleotide variability at G6PD and the signature of malaria selection in humans, Genetics, 162, 1849, 10.1093/genetics/162.4.1849 · DOI · Paper page
- YT Liu, 2000, Rapid detection of a-thalassaemia deletions and a-globin gene triplication by multiplex polymerase chain reactions, Brit J Haematol, 108, 295, 10.1046/j.1365-2141.2000.01870.x · DOI · Paper page
- I Setianingsih, 2003, Alpha thalassemia in Indonesia: phenotypes and molecular defects, Adv Exp Med Biol, 531, 47, 10.1007/978-1-4615-0059-9_4 · doi:10.1007/978-1-4615-0059-9_4
- O Ainoon, 2003, Semiquantitative screening test for G6PD deficiency detects severe deficiency but misses a substantial proportion of partially-deficient females, Southeast Asian J Trop Med Public Health, 34, 405
- JK Baird, Point-of-care G6PD diagnostics for Plasmodium vivax malaria is clinical and public health urgency, BMC Med
- A Roca-Feltrer, 2014, Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia, PLoS One, 9, e116143, 10.1371/journal.pone.0116143 · DOI · Paper page
- D Adu-Gyasi, 2015, Evaluation of the diagnostic accuracy of the CareStart G6PD deficiency rapid diagnostic test (RDT) in a malaria endemic area in Ghana, Africa, PLoS One, 10, e0125796, 10.1371/journal.pone.0125796 · doi:10.1371/journal.pone.0125796
- ME von Fricken, 2014, Performance of the CareStart glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in Gressier, Haiti, Am J Trop Med Hyg, 91, 77, 10.4269/ajtmh.14-0100 · doi:10.4269/ajtmh.14-0100
- G Bancone, 2015, Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests, Am J Trop Med Hyg, 92, 818, 10.4269/ajtmh.14-0696 · DOI · Paper page
Cited by
Watson, J., Taylor, W. R. J., Bancone, G., Chu, C. S., Jittamala, P., & White, N. J. (2018) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0006440 · Cited by 77
Satyagraha, A. W., Sadhewa, A., Panggalo, L. V., Subekti, D., Elyazar, I., Soebianto, S., Mahpud, N., Harahap, A. R., & Baird, J. K. (2021) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0009610 · Cited by 12
Self-citationTaylor, W. R. J., Kim, S., Kheng, S., Muth, S., Tor, P., Christophel, E., Mukaka, M., Kerleguer, A., Luzzatto, L., Baird, J. K., et al. (2021) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0009690 · Cited by 9
Self-citation
Metadata
- Authors
- Satyagraha, A. W., Sadhewa, A., Elvira, R., Elyazar, I., Feriandika, D., Antonjaya, U., Oyong, D., Subekti, D., Rozi, I. E., Domingo, G. J., Harahap, A. R., & Baird, J. K.
- Venue
- PLOS Neglected Tropical Diseases
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-02-19
- Volume
- 10
- Issue
- 2
- Pages
- e0004457
- ISSN
- 1935-2735
- Cited by
- 41
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.